Re:AstraZeneca may have provided incomplete efficacy data NIAID
by ceejayoz on Tuesday March 23, 2021 @02:23PM
(#26558370)
They submitted the analysis of the Phase III trials for publication in February. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3777268
> There were no hospitalisations in the ChAdOx1 nCoV-19 group after the initial 21 day exclusion period, and 15 in the control group.
You can disbelieve it, if you like, but you can hardly accuse them of not publishing it.
And if am not wrong, they should be publishing the final report based on this research.